Contraception
Open Access
Numéro
Med Sci (Paris)
Volume 38, Numéro 5, Mai 2022
Contraception
Page(s) 457 - 463
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2022058
Publié en ligne 24 mai 2022
  1. United Nations, Department of Economic and Social Affairs, Population Division (2019). Contraceptive Use by Method 2019: Data Booklet (ST/ESA/SER.A/435). [Google Scholar]
  2. Sundaram A, Vaughan B, Kost K, et al. Contraceptive failure in the United States: Estimates from the 2006–2010 National Survey of Family Growth. Perspect Sex Reprod Health 2017 ; 49 : 7–16. [CrossRef] [PubMed] [Google Scholar]
  3. Islam MS, Afrin S, Jones SI, Segars J. Selective Progesterone Receptor Modulators-Mechanisms and Therapeutic Utility. Endocr Rev 2020; 41(5) : bnaa012. [CrossRef] [PubMed] [Google Scholar]
  4. Curtis KM, Peipert JF. Long-Acting Reversible Contraception. N Engl J Med 2017 ; 376 : 461–468. [CrossRef] [PubMed] [Google Scholar]
  5. Moreau C, Bohet A, Le Guen M, et al. FECOND Group Unplanned or unwanted? A randomized study of national estimates of pregnancy intentions. Fertil Steril 2014 ; 102 : 1663–1670. [CrossRef] [PubMed] [Google Scholar]
  6. Sundaram A, Vaughan B, Kost K, et al. Contraceptive failure in the United States: estimates from the 2006–2010 National Survey of Family Growth. Perspect Sex Reprod Health 2017 ; 49 : 7–16. [CrossRef] [PubMed] [Google Scholar]
  7. Bongaarts J, O’Neill BC. Global warming policy: is population left out in the cold?. Science 2018 ; 361 : 650–652. [CrossRef] [PubMed] [Google Scholar]
  8. https://www.guttmacher.org/united-states/abortion. [Google Scholar]
  9. https://drees.solidarites-sante.gouv.fr/sides/default/files/2021-02/ER%201163.pdf. [Google Scholar]
  10. https://drees.solidarites-sante.gouv.fr/sides/default/files/2021-09/ER1207_0.pdf. [Google Scholar]
  11. Warasna B, Rajabi N, Mustafa B, et al. Knowledge and attitude of Palestinian women to contraceptives: a cross-sectional study. Lancet 2021; 398 : S45. [CrossRef] [PubMed] [Google Scholar]
  12. Kamijo K, Kataoka Y, Shigemi D. Challenges of accessing emergency contraceptive pills in Japan. BMJ Sex Reprod Health 2021; 47 : 232–3. [CrossRef] [PubMed] [Google Scholar]
  13. https://www.interieur.gouv.fr/Archives/Archives-des-dossiers/2017-Dossiers/Le-developpement-durable-au-ministere-de-l-Interieur/L-agenda-2030-de-l-ONU-les-Objectifs-Developpement-Durable. [Google Scholar]
  14. Starrs AM, Ezeh AC, Barker G, et al. Accelerate progress—sexual and reproductive health and rights for all: report of the Guttmacher-Lancet Commission. Lancet 2018 ; 391 : 2642–2692. [CrossRef] [PubMed] [Google Scholar]
  15. https///solidarites-sante.gouv.fr/IMG/pdf/strategie_nationale_sante_sexuelle.pdf. [Google Scholar]
  16. Ahmed S, Li Q, Liu L, Tsui AO. Maternal deaths averted by contraceptive use: an analysis of 172 countries. Lancet 2012 ; 380 : 111–125. [CrossRef] [PubMed] [Google Scholar]
  17. Cleland J, Bernstein S, Ezeh A, et al. Family planning: the unfinished agenda. Lancet 2006 ; 368 : 1810–1827. [CrossRef] [PubMed] [Google Scholar]
  18. Tran NT, Seuc A, Coulibaly A, et al. Post-partum family planning in Burkina Faso (Yam Daabo): a two group, multi-intervention, single-blinded, cluster-randomised controlled trial. Lancet Glob Health 2019 ; 7 : e1109–e1117. [CrossRef] [PubMed] [Google Scholar]
  19. Toan Tran N, Seuc A, Tshikaya B, et al. Effectiveness of post-partum family planning interventions on contraceptive use and method mix at 1 year after childbirth in Kinshasa, DR Congo (Yam Daabo): a single-blind, cluster-randomised controlled trial. Lancet Glob Health 2020; 8 : e399–e410. [CrossRef] [PubMed] [Google Scholar]
  20. National Institute for Health and Care Excellence. Long-Acting reversible contraception: the effective and appropriate use of long-acting reversible contraception, 2005. https:// www.nice.org.uk/guidance/cg30/evidence/full-guideline-pdf194840607. [Google Scholar]
  21. Pasvol TJ, McGregor EA, Rait G, Horsfall L. Time trends in contraceptive prescribing in UK primary care 2000–2018: a repeated cross-sectional study. BMJ Sex Repro Health 2021; bmjsrh-2021-201260. [Google Scholar]
  22. Glasier A, Baraitser P, McDaid L, et al. Emergency contraception from the pharmacy 20 years on: a mystery shopper study. BMJ Sex Reprod Health 2021; 47 : 55–60. [CrossRef] [PubMed] [Google Scholar]
  23. Cameron ST, Glasier A, McDaid A, et al. Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial. Lancet 2020; 396 : 1585–94. [CrossRef] [PubMed] [Google Scholar]
  24. Ries Thurman A, Schwartz JL, Brache V, et al. Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women. PLoS One 2018; 13 : e0199778. [CrossRef] [PubMed] [Google Scholar]
  25. Duffy DM. Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway. Hum Reprod Update 2015 ; 21 : 652–670. [CrossRef] [PubMed] [Google Scholar]
  26. Glasier A.. Acceptability of contraception for men: a review. Contraception 2010 ; 82 : 453–456. [CrossRef] [PubMed] [Google Scholar]
  27. Long JE, Lee JE, Blithe DL. Novel Hormonal and Nonhormonal Male Contraceptive Development. J Clin Endocrinol Metab 2021; 106 : e2381–92. [CrossRef] [PubMed] [Google Scholar]
  28. Jain T, Schwarz EB, Mehrotra A. A study of telecontraception. N Engl J Med 2019 ; 381 : 1287–1288. [CrossRef] [PubMed] [Google Scholar]
  29. Sadeghi I, Byrne J, Shakur R, Langer R. Engineered drug delivery devices to address Global Health challenges. J Control Release 2021; 331 : 503–14. [CrossRef] [PubMed] [Google Scholar]
  30. Al Dalaty A, Gualeni B, Coulman S, Birchall J. Models and methods to characterise levonorgestrel release from intradermally administered contraceptives. Drug Deliv Transl Res 2022; 12 : 335–49. [CrossRef] [PubMed] [Google Scholar]
  31. Kirtane AR, Hua T, Hayward A, et al. A once-a-month oral contraceptive. Sci Transl Med 2019; 11 : eaay2602. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.